Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $45.1 million.

  • Aveanna Healthcare Holdings' Net Cash Flow rose 4651.47% to $45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.4 million, marking a year-over-year increase of 12342.88%. This contributed to the annual value of $40.3 million for FY2024, which is 6317.9% up from last year.
  • Latest data reveals that Aveanna Healthcare Holdings reported Net Cash Flow of $45.1 million as of Q3 2025, which was up 4651.47% from $29.2 million recorded in Q2 2025.
  • In the past 5 years, Aveanna Healthcare Holdings' Net Cash Flow registered a high of $46.2 million during Q4 2022, and its lowest value of -$375.8 million during Q1 2022.
  • Moreover, its 5-year median value for Net Cash Flow was $24000.0 (2022), whereas its average is -$19.5 million.
  • In the last 5 years, Aveanna Healthcare Holdings' Net Cash Flow plummeted by 2685416.67% in 2023 and then surged by 47863.08% in 2025.
  • Quarter analysis of 5 years shows Aveanna Healthcare Holdings' Net Cash Flow stood at -$70.2 million in 2021, then skyrocketed by 36.7% to -$44.5 million in 2022, then surged by 90.21% to -$4.4 million in 2023, then soared by 233.87% to $5.8 million in 2024, then soared by 674.6% to $45.1 million in 2025.
  • Its Net Cash Flow was $45.1 million in Q3 2025, compared to $29.2 million in Q2 2025 and -$12.8 million in Q1 2025.